275 related articles for article (PubMed ID: 16957809)
1. Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent.
Hamed SH; Sriwiriyanont P; deLong MA; Visscher MO; Wickett RR; Boissy RE
J Cosmet Sci; 2006; 57(4):291-308. PubMed ID: 16957809
[TBL] [Abstract][Full Text] [Related]
2. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency.
Boissy RE; Visscher M; DeLong MA
Exp Dermatol; 2005 Aug; 14(8):601-8. PubMed ID: 16026582
[TBL] [Abstract][Full Text] [Related]
3. DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis.
Chawla S; Kvalnes K; deLong MA; Wickett R; Manga P; Boissy RE
J Drugs Dermatol; 2012 Oct; 11(10):e28-34. PubMed ID: 23134995
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives.
Chawla S; deLong MA; Visscher MO; Wickett RR; Manga P; Boissy RE
Br J Dermatol; 2008 Dec; 159(6):1267-74. PubMed ID: 18811684
[TBL] [Abstract][Full Text] [Related]
5. Effects of hydroquinone and its glucoside derivatives on melanogenesis and antioxidation: Biosafety as skin whitening agents.
Hu ZM; Zhou Q; Lei TC; Ding SF; Xu SZ
J Dermatol Sci; 2009 Sep; 55(3):179-84. PubMed ID: 19574027
[TBL] [Abstract][Full Text] [Related]
6. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
[TBL] [Abstract][Full Text] [Related]
7. Potent low toxicity inhibition of human melanogenesis by novel indole-containing octapeptides.
Ubeid AA; Do S; Nye C; Hantash BM
Biochim Biophys Acta; 2012 Oct; 1820(10):1481-9. PubMed ID: 22609875
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
[TBL] [Abstract][Full Text] [Related]
9. Anti-Pigmentation Effects of Eight
Ahn HY; Choo YM; Cho YS
J Microbiol Biotechnol; 2018 Mar; 28(3):375-380. PubMed ID: 29316744
[TBL] [Abstract][Full Text] [Related]
10. Tyrosinase modulation by five Rwandese herbal medicines traditionally used for skin treatment.
Kamagaju L; Morandini R; Bizuru E; Nyetera P; Nduwayezu JB; Stévigny C; Ghanem G; Duez P
J Ethnopharmacol; 2013 Apr; 146(3):824-34. PubMed ID: 23439030
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues.
Xiao L; Matsubayashi K; Miwa N
Arch Dermatol Res; 2007 Aug; 299(5-6):245-57. PubMed ID: 17333222
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of melanin content by Punicalagins in the super fruit pomegranate (Punica granatum).
Rana J; Diwakar G; Saito L; Scholten JD; Mulder T
J Cosmet Sci; 2013; 64(6):445-53. PubMed ID: 24397882
[TBL] [Abstract][Full Text] [Related]
13. Effect of deoxyarbutin on melanogenesis: in vivo comparison with other melanogenesis inhibitor.
Hamed SH; Sriwiiyanont P; Wickett RR; Boissy R
J Cosmet Sci; 2004; 55(1):118-9. PubMed ID: 15065582
[No Abstract] [Full Text] [Related]
14. Arbutin: mechanism of its depigmenting action in human melanocyte culture.
Maeda K; Fukuda M
J Pharmacol Exp Ther; 1996 Feb; 276(2):765-9. PubMed ID: 8632348
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors.
Curto EV; Kwong C; Hermersdörfer H; Glatt H; Santis C; Virador V; Hearing VJ; Dooley TP
Biochem Pharmacol; 1999 Mar; 57(6):663-72. PubMed ID: 10037452
[TBL] [Abstract][Full Text] [Related]
16. Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity.
Bang SH; Han SJ; Kim DH
J Cosmet Dermatol; 2008 Sep; 7(3):189-93. PubMed ID: 18789053
[TBL] [Abstract][Full Text] [Related]
17. Short-sequence oligopeptides with inhibitory activity against mushroom and human tyrosinase.
Abu Ubeid A; Zhao L; Wang Y; Hantash BM
J Invest Dermatol; 2009 Sep; 129(9):2242-9. PubMed ID: 19440221
[TBL] [Abstract][Full Text] [Related]
18. Study of Hydroquinone Mediated Cytotoxicity and Hypopigmentation Effects from UVB-Irradiated Arbutin and DeoxyArbutin.
Chang NF; Chen YS; Lin YJ; Tai TH; Chen AN; Huang CH; Lin CC
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467382
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation.
Won YK; Loy CJ; Randhawa M; Southall MD
Arch Dermatol Res; 2014 Jul; 306(5):455-65. PubMed ID: 24402285
[TBL] [Abstract][Full Text] [Related]
20. Identifying melanogenesis inhibitors from Cinnamomum subavenium with in vitro and in vivo screening systems by targeting the human tyrosinase.
Wang HM; Chen CY; Wen ZH
Exp Dermatol; 2011 Mar; 20(3):242-8. PubMed ID: 21054558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
